The clinical Spectrum of Viridans Group Streptococci infections in paediatric patients at a tertiary hospital

被引:0
|
作者
Shongwe, Nkosinathi S. [1 ]
Mabena, Fikile C. [1 ,2 ]
Wadula, Jeannette [3 ,4 ]
Petersen, Karen [1 ,2 ]
机构
[1] Univ Witwatersrand, Fac Hlth Sci, Dept Paediat & Child Hlth, Johannesburg, South Africa
[2] Chris Hani Baragwanath Acad Hosp, Dept Paediat & Child Hlth, Johannesburg, South Africa
[3] Univ Witwatersrand, Fac Hlth Sci, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa
[4] Chris Hani Baragwanath Acad Hosp, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa
关键词
Viridans Group Streptococcus; antibiotics; susceptibility; clinical presentation; organism; ANTIMICROBIAL SUSCEPTIBILITY; BACTEREMIA; RESISTANCE; CHILDREN; SEPSIS; COUNT;
D O I
10.4102/sajid.v39i1.563
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Viridans Group Streptococci (VGS) are often considered organisms of low virulence; however, infection can result in clinically significant sepsis and life-threatening complications in paediatric patients. Objectives: This study aimed to describe the spectrum of clinical presentation of VGS bacteraemia in paediatric patients, to analyse risk factors, and to describe the antibiotics resistance patterns of VGS. Method: Cultures of VGS in paediatric patients admitted to Chris Hani Baragwanath Academic Hospital in 2019 were identified through National Health Laboratory Service. Data were extracted from archived clinical records and analysed. Sepsis scores were calculated at the time of bacteraemia. Results: A total of 133 cultures were identified; 64 (48.1 % ) polymicrobial cultures and no records 4 (0.03 % ) were excluded; 65 (48.9 % ) were analysed. The median age was 1.5 months (range 0.03 to 168, interquartile range [IQR]: 0.3-13.25), 27/65 (42 % ) were neonates. The median duration of hospitalisation was 7 days (IQR: 3-21). The commonest diagnoses were neonatal sepsis 30.8 % ( n = 20) and pneumonia 28 % ( n = 18). The systemic inflammatory response syndrome (SIRS) score was >= 2 in 57 % (16/28) patients; paediatric sequential organ failure assessment (pSOFA) score was > 2 in 10/24 (42 % ). Fifty-seven (88 % ) patients were discharged; three (5 % ) required ICU admission and 8/65 (12.3 % ) died. Malnutrition was present in 50 % of patients who died. Cephalosporins and penicillin had sensitivity of 89 % and 55 %, respectively. Conclusion: Viridans Group Streptococci bacteraemia was common in neonates, and pneumonia was a common presentation in this cohort. The VGS bacteraemia was associated with morbidity and deaths in this cohort. Contribution: The VGS should be considered a significant organism when cultured from sterile sites and routine antibiotic susceptibility testing should be performed. Prospective studies are recommended.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Fluoroquinolone resistance mutations in the DNA topoisomerase II genes of viridans group streptococci clinical isolates
    Balas, D
    González, I
    Georgiou, M
    Alcaide, F
    Liñares, J
    De la Campa, AG
    DRUGS, 1999, 58 (Suppl 2) : 125 - 127
  • [42] Clinical characteristics and outcome of infective endocarditis due to Abiotrophia and Granulicatella compared to Viridans group streptococci
    Tellez, Adrian
    Ambrosioni, Juan
    Hernandez-Meneses, Marta
    Llopis, Jaume
    Ripa, Marco
    Chambers, Stephen T.
    Holland, David
    Almela, Manel
    Fernandez-Hidalgo, Nuria
    Almirante, Benito
    Bouza, Emilio
    Strahilevitz, Jacob
    Hannan, Margaret M.
    Harkness, John
    Kanafani, Zeina A.
    Lalani, Tahaniyat
    Lang, Selwyn
    Raymond, Nigel
    Read, Kerry
    Vinogradova, Tatiana
    Woods, Christopher W.
    Wray, Dannah
    Moreno, Asuncion
    Chu, Vivian H.
    Miro, Jose M.
    JOURNAL OF INFECTION, 2022, 85 (02) : 137 - 146
  • [43] Fluoroquinolone Resistance Mutations in the DNA Topoisomerase II Genes of Viridans Group Streptococci Clinical Isolates
    Delia Balas
    Irene González
    Marios Georgiou
    Fernando Alcaide
    Josefina Liñares
    Adela G. De La Campa
    Drugs, 1999, 58 : 125 - 127
  • [44] Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci
    González, I
    Georgiou, M
    Alcaide, F
    Balas, D
    Liñares, J
    De la Campa, AG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) : 2792 - 2798
  • [45] Spectrum of Opportunistic Fungal Infections in HIV/AIDS Patients in Tertiary Care Hospital in India
    Kaur, Ravinder
    Dhakad, Megh S.
    Goyal, Ritu
    Bhalla, Preena
    Dewan, Richa
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2016, 2016
  • [46] HOSPITAL OUTBREAK OF INFECTIONS WITH GROUP A STREPTOCOCCI TRACED TO AN ASYMPTOMATIC ANAL CARRIER
    SCHAFFNER, W
    LEFKOWITZ, LB
    GOODMAN, JS
    KOENIG, MG
    NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (22): : 1224 - +
  • [47] Paediatric patient family engagement with clinical research at a tertiary care paediatric hospital
    Gill, Carson
    Ansermino, Mark J.
    Sanatani, Shubhayan
    Mulpuri, Kishore
    Quynh Doan
    PAEDIATRICS & CHILD HEALTH, 2014, 19 (10) : 537 - 542
  • [48] Clinical and microbiological characteristics of serious infections caused by group A streptococci
    Hupkova, H.
    Zaborska, M.
    Sisovsky, V
    Babal, P.
    Simaljakova, M.
    Koren, M.
    Reis, R.
    Kozakova, J.
    Bican, D.
    EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2014, 63 (03): : 164 - 167
  • [49] Clinical profile and outcomes of paediatric patients with diabetic ketoacidosis at a tertiary care hospital in Pakistan
    Syed, Madiha
    Khawaja, Fariha Batool
    Saleem, Taimur
    Khalid, Umair
    Rashid, Abdul
    Humayun, Khadija Nuzhat
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2011, 61 (11) : 1082 - 1087
  • [50] Clinical and economic analysis of hospital acquired infections in patients diagnosed with brain tumor in a tertiary hospital
    Undabeitia, J.
    Liu, B. G.
    Catalan, G.
    Bilbao, G.
    Pomposo, I.
    Garibi, J. M.
    NEUROCIRUGIA, 2011, 22 (06): : 535 - 541